These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2153411)

  • 1. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2.
    Sato R; Imanaka T; Takano T
    Biochim Biophys Acta; 1990 Jan; 1042(1):36-41. PubMed ID: 2153411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
    Craig WY; Nutik R; Cooper AD
    J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells.
    Ooyen C; Zecca A; Bersino AM; Catapano AL
    Atherosclerosis; 1999 Jul; 145(1):87-95. PubMed ID: 10428299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CS-514, an inhibitor of HMG-CoA reductase, on serum lipids in healthy volunteers.
    Nakaya N; Homma Y; Tamachi H; Goto Y
    Atherosclerosis; 1986 Aug; 61(2):125-8. PubMed ID: 3092836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.
    Kaptein A; Roodenburg L; Princen HM
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):557-64. PubMed ID: 1654887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of apolipoprotein E-rich LDL by the liver. The effect of dietary cholesterol and some lipid lowering agents.
    Teramoto T; Matsushima T; Horie Y; Watanabe T
    Ann N Y Acad Sci; 1990; 598():301-7. PubMed ID: 2123378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein synthesis and secretion in Hep G2 cells: effects of monensin and cycloheximide.
    Hahn SE; Parkes JG; Goldberg DM
    Biochem Cell Biol; 1992 Dec; 70(12):1339-46. PubMed ID: 1338570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract]   [Full Text] [Related]  

  • 12. Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase.
    Shaw MK; Newton RS; Sliskovic DR; Roth BD; Ferguson E; Krause BR
    Biochem Biophys Res Commun; 1990 Jul; 170(2):726-34. PubMed ID: 2166504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells.
    Carlson TL; Kottke BA
    Biochem J; 1989 Nov; 264(1):241-7. PubMed ID: 2513806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of low-density lipoprotein receptors as estimated from concentrations of apolipoprotein B and C-II in serum.
    Ito H; Naito C; Hayashi H; Kawamura M
    Clin Chem; 1988 Nov; 34(11):2224-7. PubMed ID: 3141083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between apolipoprotein B-100 and low-density lipoprotein cholesterol after treatment with an HMG CoA reductase inhibitor.
    Levinson SS; Blevins RD; Smith MP; Rubinfire M; Maciejko JJ
    Am J Clin Pathol; 1989 Oct; 92(4):479-83. PubMed ID: 2508466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CS-514, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on lipoprotein and apolipoprotein in plasma of hypercholesterolemic diabetics.
    Yoshino G; Kazumi T; Kasama T; Iwatani I; Iwai M; Inui A; Otsuki M; Baba S
    Diabetes Res Clin Pract; 1986 Jun; 2(3):179-81. PubMed ID: 3091343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2.
    Tam SP; Ramharack R
    Atherosclerosis; 1992 Aug; 95(2-3):137-46. PubMed ID: 1329783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters.
    Koide K; Hayashi K; Horiuchi I; Kajiyama G
    Biochim Biophys Acta; 1989 Sep; 1005(1):65-71. PubMed ID: 2505850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.